Zoledronic acid (Aclasta) ; once yearly treatment for post-menopausal osteoporosis: horizon scanning technology briefing

Record ID 32007000139
Authors' objectives:

This study examines the use of zoledronic acid (Aclasta) for post-menopausal osteoporosis.

Authors' methods: Review
Project Status: Completed
Year Published: 2006
URL for published report: http://www.hsric.nihr.ac.uk/search
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England
MeSH Terms
  • Bone Density Conservation Agents
  • Osteoporosis, Postmenopausal
Organisation Name: NIHR Horizon Scanning Centre
Contact Address: The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name: c.packer@bham.ac.uk
Contact Email: c.packer@bham.ac.uk
Copyright: National Horizon Scanning Centre (NHSC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.